Ukinuta odobrenja, povlačenje serija lijekova, pisma zdravstvenim radnicima i novi lijekovi EU — svakodnevno, automatski. Zadnje ažuriranje: 3. 10. 2026. 08:55
Izvori: promjene pratimo na temelju informacija Agencije za lijekove i medicinske proizvode (HALMED) — rješenja o ukidanju odobrenja, obavijesti o povlačenju serija i pisma zdravstvenim radnicima. Odluke o centralizirano odobrenim lijekovima dolaze iz registra Unije Europske komisije (oznaka EU). Nestašice i liste lijekova HZZO-a ovdje (još) nisu uključene.
br. EU/1/25/1977 · Zurzuvae is indicated for the treatment of postpartum depression (PPD) in adults following childbirth (see sec… · Biogen Netherlands B.V. · Zuranolone · ATC N06AX31
br. EU/1/25/1912 · Voranigo as monotherapy is indicated for the treatment of predominantly non enhancing Grade 2 astrocytoma or o… · Les Laboratoires Servier · vorasidenib · ATC L01XM04
br. EU/1/25/1969 · Tryngolza is indicated as an adjunct to diet in adult patients for the treatment of genetically confirmed fami… · Swedish Orphan Biovitrum AB (publ) · olezarsen · ATC Pending
br. EU/1/25/1975 · Ekterly is indicated for symptomatic treatment of acute attacks of hereditary angioedema (HAE) in adults and a… · KalVista Pharmaceuticals (Ireland) Ltd · sebetralstat · ATC B06AC08
br. EU/1/25/1978 · Treatment of osteoporosis in postmenopausal women and in men at increased risk of fractures. In postmenopausal… · SciencePharma Sp. z o.o. · denosumab · ATC M05BX04
Lekoskop